Mirum Pharmaceuticals (MIRM) 10-Q2021 Q1 Quarterly report

Filed: 6 May 21, 4:17pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. senior Avg

New words: AAV, accrual, affiliate, affirmative, anesthesiologist, Australia, ballot, behavior, bifurcation, broadening, buyer, CANbridge, capsid, capture, Cara, Carlo, chemistry, compound, constitute, constitutionality, credential, CSPA, customary, cybercrime, cybersecurity, delete, depression, diverge, divergence, divergent, Dutch, EEA, elafibranor, EMBARK, embedded, endeavor, enumerated, espionage, EU, exceeding, exiting, explicit, exploited, expressly, February, forecasted, foreclosure, free, functional, Genfit, hacking, home, Hong, honor, host, immunologic, indemnification, ingredient, instrument, issuable, Kong, Korsuva, legislature, lowest, LP, Macau, malfeasance, malware, meantime, methodology, Monte, Mulholland, nationwide, network, Northern, Oberland, OHANA, open, overturning, PDUFA, perspective, phishing, point, prioritizing, prospective, protein, pseudonymized, PSU, ransomware, reaction, recession, reconsider, remeasurement, repaid, repayment, retrospective, RIPA, SA, SAS, seamlessly, segment, segregation, simulation, social, software, sophisticated, stream, stuffing, Subtopic, suspected, Taiwan, Takeda, territory, TPC, transmit, trend, uncured, underwritten, unexercised, uninsured, uninterrupted, unnecessary, virtue, Vivet, VWAP, waiver, warranted, wider, withdrew

Removed: adjusted, AG, allocating, allocation, Amsterdam, beneficiary, biometric, biosimilar, Blueprint, calculate, calculating, calling, cap, cenicriviroc, certiorari, circumvent, closure, codified, Commencing, comprehensive, converted, determinable, distancing, effected, electrical, emerge, enterprise, establishing, extraordinary, extraterritorially, feature, founder, France, generating, generation, incentivize, intraperiod, itching, laid, lessor, London, marketability, mezzanine, monthly, paired, par, pocket, project, projected, proportional, proposal, purpose, quarantine, reclassified, recognizing, redemption, relocated, rendered, repeal, retroactive, satisfying, screen, settled, Simplifying, solicited, split, step, strain, subjected, Task, telecommunication, track, Trump, TSA, weighted, wholly

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated MIRM transcripts

MIRM similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Mirum Pharmaceuticals, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)

The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: May 6, 2021

By:

/s/ Christopher Peetz

Christopher Peetz

President and Chief Executive Officer

(Principal Executive Officer)